210 related articles for article (PubMed ID: 18438698)
1. Increased severity over generations of Charcot-Marie-Tooth disease type 1A.
Steiner I; Gotkine M; Steiner-Birmanns B; Biran I; Silverstein S; Abeliovich D; Argov Z; Wirguin I
J Neurol; 2008 Jun; 255(6):813-9. PubMed ID: 18438698
[TBL] [Abstract][Full Text] [Related]
2. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases.
Birouk N; Gouider R; Le Guern E; Gugenheim M; Tardieu S; Maisonobe T; Le Forestier N; Agid Y; Brice A; Bouche P
Brain; 1997 May; 120 ( Pt 5)():813-23. PubMed ID: 9183252
[TBL] [Abstract][Full Text] [Related]
3. Severe phenotypes in a Charcot-Marie-Tooth 1A patient with PMP22 triplication.
Kim SM; Lee J; Yoon BR; Kim YJ; Choi BO; Chung KW
J Hum Genet; 2015 Feb; 60(2):103-6. PubMed ID: 25500726
[TBL] [Abstract][Full Text] [Related]
4. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
5. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology, demographic, and clinical characteristics of Charcot-Marie-tooth disease in the island of Gran Canaria (Spain).
Lousa M; Vázquez-Huarte-Mendicoa C; Gutiérrez AJ; Saavedra P; Navarro B; Tugores A
J Peripher Nerv Syst; 2019 Mar; 24(1):131-138. PubMed ID: 30569560
[TBL] [Abstract][Full Text] [Related]
7. Application of multiplex ligation-dependent probe analysis to define a small deletion encompassing PMP22 exons 4 and 5 in hereditary neuropathy with liability to pressure palsies.
Sutton IJ; Mocroft AP; Lindley VH; Barber RM; Bryon RJ; Winer JB; MacDonald F
Neuromuscul Disord; 2004 Dec; 14(12):804-9. PubMed ID: 15564036
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of Charcot-Marie-Tooth disease type 1A: gene dosage as a novel mechanism for a common autosomal dominant condition.
Roa BB; Lupski JR
Am J Med Sci; 1993 Sep; 306(3):177-84. PubMed ID: 8128981
[TBL] [Abstract][Full Text] [Related]
9. Anticipation in a unique family with Charcot-Marie-Tooth syndrome and deafness: delineation of the clinical features and review of the literature.
Kovach MJ; Campbell KC; Herman K; Waggoner B; Gelber D; Hughes LF; Kimonis VE
Am J Med Genet; 2002 Apr; 108(4):295-303. PubMed ID: 11920834
[TBL] [Abstract][Full Text] [Related]
10. Charcot-Marie-Tooth phenotype produced by a duplicated PMP22 gene as part of a 17p trisomy-translocation to the X chromosome.
King PH; Waldrop R; Lupski JR; Shaffer LG
Clin Genet; 1998 Nov; 54(5):413-6. PubMed ID: 9842994
[TBL] [Abstract][Full Text] [Related]
11. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
12. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1 neuropathy.
Roa BB; Greenberg F; Gunaratne P; Sauer CM; Lubinsky MS; Kozma C; Meck JM; Magenis RE; Shaffer LG; Lupski JR
Hum Genet; 1996 May; 97(5):642-9. PubMed ID: 8655146
[TBL] [Abstract][Full Text] [Related]
13. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
[TBL] [Abstract][Full Text] [Related]
14. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
Roa BB; Garcia CA; Lupski JR
Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
[TBL] [Abstract][Full Text] [Related]
15. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
16. Detection of Charcot-Marie-Tooth type 1A duplication by the polymerase chain reaction.
Blair IP; Kennerson ML; Nicholson GA
Clin Chem; 1995 Aug; 41(8 Pt 1):1105-8. PubMed ID: 7628084
[TBL] [Abstract][Full Text] [Related]
17. [Detection of the PMP22 gene duplication in peripheral neuropathy patients: a study in Mexican population].
Cortés H; Hernández-Hernández Ó; Bautista-Tirado T; Escobar-Cedillo RE; Magaña JJ; Leyva-García N
Rev Neurol; 2014 Aug; 59(3):111-7. PubMed ID: 25030070
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics and neuropathology of Charcot-Marie-Tooth disease type 1A.
Lupski JR; Garcia CA
Brain Pathol; 1992 Oct; 2(4):337-49. PubMed ID: 1341967
[TBL] [Abstract][Full Text] [Related]
19. Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome.
Yuan B; Harel T; Gu S; Liu P; Burglen L; Chantot-Bastaraud S; Gelowani V; Beck CR; Carvalho CM; Cheung SW; Coe A; Malan V; Munnich A; Magoulas PL; Potocki L; Lupski JR
Am J Hum Genet; 2015 Nov; 97(5):691-707. PubMed ID: 26544804
[TBL] [Abstract][Full Text] [Related]
20. [A sporadic case of Charcot-Marie-Tooth disease type 1 A associated with a duplication in chromosome 17 p11.2-p12].
Inoue M; Kojima M; Aikoh H; Sugai K; Murakami N; Nonaka I; Hayasaka K; Yamamoto M; Sobue G
No To Hattatsu; 1999 Sep; 31(5):452-7. PubMed ID: 10487071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
